Such conflicting findings underscore a critical knowledge gap in our understanding of AMPK-autophagy crosstalk (33, 39, 93), with important implications for developing targeted therapies for metabolic and cardiovascular diseases (94, 96). This evidence concerns the gene PRKAA2 and cardiovascular disorder.